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A EDNA cncodinl P hunum bilirubin UDP.glucuron4~yyllrun~fcFlrrc h;rr been iralulcd and vlrrbly cxprcsocd in Chincsc timstcr V79 lun8 fibroblast 
cell Iins, Wcclcrn blolring of cdl t.omopnlllrr with nnri-UQT antibody revealed u highly upruscd pro&in af approx. 55.5 kDa in &cc. Thr 
cxpre+*cd cnqmc spaifisally cub#& kc formation of bilirubin mono- and diglucuronidcs, and alsau:~lj~~! !hc$ucuron;dtltion of MO phcnolic 
compound& which urc geod rubW:lte for orhcr human UGT isornzymcs. a: IOW fats& 
Complcmcntury DNA; Eukuryoric expression ve!or: Enzyme activity 
1 n INTRODUCTION 
UDD~glucuronosyltrunsfcrascs (UGT) arc a large 
family of cnzymcs involved in the transfer of a glucu= 
ronids group, from the cofactor UDP-glucuronic acid 
(UDPGA). to a variety of cndogcnous and cxogcnous 
substrotcs, The increased polarity of the glucuronide 
facilitates its excretion into the bile or urine [il. The 
glucuronidation of bilirubin, the end product of hacm 
catabolism, is an extremely important tiotrnnsforma- 
tisr. carried out by the liver. Abcrrutions in this function 
arc manifested in Criglcr-Najjar syndrome, a rare gc- 
nctic human disease, in which the ability to glucu- 
ronidatc bilirubin is scvcrcly reduced which results in 
ncurocoxic onscqucncss which may cvcntually lead to 
death [I]. Studies in this laboratory have sought to char- 
sctcriss the bilirubin UGT(s) involved in this important 
physiological function. 
thcsc proteins can bc studisd, something which is often 
not possible due co the scarcity of human tissue and the 
instability of proteins during purification. In this rc- 
spcct, the construction of systems which stably cxprcss 
the protein of interest have been particularly useful [ill. 
Harding CC al, [S] rcportcd the cloning and expression 
of the first UGT cDNA (termed HP11 from human 
liver. Subscqusnt work rcvcalcd a second, closely rc- 
laced isoform (HP2). also to bs present in this tissue [6]. 
These two isoforrns were cxcrcmcly interesting because 
they shared identical 3’ halves, while having only ap- 
proximately 48% identity in their 5’ half. This rt-ongly 
suggested that rhc mRNAs encoding thcsc isoforms 
wcrc produced by oltcrnacivc splicing of a primary tran- 
script. Further work rcvcalcd there to lx two more 
mcmbcrs of this gcnc family (HP3 and MDA). all sharing 
idcntisal 3’ scqucnses [4,7j. 
Only three UGTs have been purified co date from 
human liver rhnt cacalysc the glucuronidation of cstriol, 
4-aminobipbcnyl [2] and ti-hydrosy bile acids [3]. The 
purification of the cIusive human bilirubin UGT has yet 
co be reported. 
Hsrc WC report rhc stable exprsssion of one of these 
cDNA clones (HP3). which cncodcs a bilirubin trans- 
fcrasc, in P tissue culture expression system. WC have 
used this system co examine some of the biochcmicul 
properties of this important isocnzymc. 
The study of human gcnc products has been greatly 
facilitaicd by the technology of cDNA cloning. The 
subscqgcnt cxprcssion of chc polypcptidcs encoded by 
thcsc clones in hctcrologous mammalian tissue culture 
systems provides a means whcrcby the biochemistry of 
2. MATERIALS AND METHODS 
l Piwcnr urfrlrers: Institute of Gcnctics, University of Glusgow, 
Church strccl. Gl;lrgow. GI I SJS, UK. 
Corrcsprrn&ncc urlrlrcss: B. Durchcll, Dcparlmcnt of Biochcmiwl 
Medicine, Uniucrrity of Dundcc. Nincwclls l-iorpitat und Mcdicul 
School, Dundcc. DDI 9SY, Scotland, UK. Rx: (44) (382) 644620, 
2.1 I Scrcc:lillg n/ clWA librurics 
The humun IivcrcDNA libmry used for thisstudy wasa AUNIZAP 
library, purchased from Stralagcnc (Lo Jolla, CA, USA). 
The protocols used to screen the library, and to obt;lin full-length 
clones. huvc been dcxribcd in &tail clsswhcrc [4,?1, 
2.2. Rwricrinrr cligessriaru 
All rcstriclion cndonucleuses teed in this study wcrcpurchared from 
Promcya Corporulion (ivi’aLii*Jn. USA). Rmctions H’crc ciirricd oul 
under the conditions rccommcndcd by the manufticlurcr. 
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2.3. Cmsrrtrrriut~ o~plttswitlr crtrtl truqJkriur, u/ L’GT tf P3 ioru rixs,t: 
nrlrurc crlls 
Clanc pBluc&pl HP3 WCPC prepared from the oripitil &JNlZAP 
clone by in vivo excision of the plllucscript scqunrccs according IO ~bc 
mnnufucturcn instructions. The rull.lcngth HP3 cDNA (includiny 
I?onading DNA1 was rclc;rrcd from pBlucrrlpl HP3 by digestion 
with tbc restriction cndonuclcascs &rHl and X/~ul und IigaIcd [6] 
into the rukaryotk expression Ycctor pCDNAlnta (Invilrcgccn) lo 
give canarucl pCDNAIncoHP3(+). in whkh lhc HP3 frqjmml WY 
in the corrccl bricnration IO give expression from the war CMV 
aromotcrlcnhanccr, Cloninn of fhc &rrrrHU~ilrdlll tGluwximHP3 
r-m-- 
fragnrcnt into lhc pCDNATnca polylinkcr praiuccd u control con. 
struct with the HP3 inert in the opposiu (-1 orknl;lrion 
(pCDNA I ncoHPS(-Il. 
Plasmid DNA was proppicd in the d ruuli lldsl arain MClOdI (6) 
under sclcction for both kunilnrycin and ampicillin (bath 50 flglml. 
Sigma. UK) rcsistzmrc. Plusmid wns is&led using the ulkulinr lysis 
method with purifinlion on CsCt gradicnfr IX), 
Chilesc htimstcr VW lung ribrobltistr were rdutincly prawn IX de- 
scribed prcviaurly 191. Raombinant plusmid DNA (5 #y) was Iin- 
car&d with Strrll irnd mixed with I~C lrmrlcclian rcucnl DOTAP 
&chrinscr Mnnnhsim) to fueilituk introduction inlo 16ccll line und 
recombination inla lhc gcaomc. Stably rmnsfcclcd edlonicr G?ltI. 
rcristmlt) wcrc irslatcd and cultured tlx dcscribcrl by FourncKiiglcux 
CI al. [I]. Cells were nulintvincd in SCILYI~YC mcdiunr until hrveninp. 
2.4. dnulpx uf rimtr rrrl~~rrr cdl I~uwrr~grrnfm rutd limr j#rirrawur#rcr 
Y79 cclh stably lrilnsfcclcd with HP3 cDNA were grown IO 70% 
conflucncy and lhcn harvested. Cells wcrc washed twice with PUS 
s&lion prior IO furihcr tmulyrlr. Liver misroramcs wcrc prcparcd 
from tissue samples us previously described [I], SDSqolyacrylamidc 
gel clccfrapharcsir nnd Western blottin): of the tirsuc ranlplcr WIS as 
dusribcd previously (7.9). 
Assay af UCiTrctiviGcs in ccl1 homogcn;ltar und humnn ilvcr micro- 
soma was dcicb&cd by TLC assay [IO) using 0.5 mM substmtc and 
2 mM UDP glucuronic acid +xnlaining 0.2 pCi10.66 nmol “C label 
from NEN. UK). nilirubin UGT uclivity was dclcrmincd by incuba. 
tion of alt homogcnotcr or human liver nricrosamcr with 112 PM 
bilirubin und IO mM UDP &uzuronic acid; the glucuronidcr fonncd 
wcrc antrlyscd by HPLC a~; previously dracribcd by Odcll(1 I]. Protein 
lcvcls wcrc assaayol by lhc Lowry mcthad [I?] using bovine scrum 
albumin ns standard. 
3. RESULTS AND DISCUSSION 
Mnrbitr UDPGT 
A DNA probe prcparcd from the humiln UGT 
cDNA NP2 [6] wt\s used to scrscn u hun~n liver & 
UnizapcDNA library under conditions of relaxed strin- 
gency. A number of related UGT cDN.A.‘s were isolated 
using this procedure. One clor~e, SH48, was judged. by 
comparison with other cloned UGT [5&J, to bc long 
enough to encode a full-length UGT protein, with 18 
nuclcotidcs upstream of the AUG initiation codon. 
Clone SH48 was idcnticai with sequences which had 
previously been churactrriscd in this laboratory LLS par- 
tial UGT cDNAs and classified as HP3 [41 and to the 
HBrl cDNA isolated by [l3], WC thcrcforc dccidcd to 
USC clone SW48 in u study of the activity of isoform HP3 
in a tissue culture cxprcssion system, 
3.2. Exptwsion OJ UGT-HP3 itI ~isstre clrltrtrc ceifs 
To check thnt the pCDNAlncoHP3 constructs were 
expressing UGT-HP3 correctly. Cos-7 cells were trun- 
ricntly t runsfcctcd with plusmido pcDNA 1 neoHP3(*) 
;md pcDNAlncoHP3(-). Transfccted cells were hur- 
vested ;tnd assayed for UDPGT activity with bilirubin 
provided PS thr substrutc. Cc!ls which had been truns- 
fectcd with pcDNAncoHP3(+) showed high UGT astiv- 
icy towards bilirubin. whereas, as expected, the 
pcDNA I ncoHP3(-) trunsfrctcd cells were inoctivc to- 
wards bilirubin (9 datu not shown). The same HP3 cx- 
prcssion constructs wcrc therefore used to stably tmns- 
feet V79 cells using G418 resistance as the dominant 
sclcctnbIc marker. V79 cells had been ass:Lycd prcvi- 
ously and found to htlvc no detectable UDPGT activity 
towurds bilirubin. Six G418’ colonies wcrc isolated and 
the cells from ctlch were grown und assayed for bilirubin 
UGT activity. Five of the six ccl1 lines wcrc found to 
have high UDPGT activity towards tllia substrate. The 
cell line V79-HP3.3 wus chosen for further study bc- 
cause it showed the highest activity. compamblc to 
thoric found in human liver microsomcs (Table I). The 
activity of this cell line uppcarcd to bc stnblc with in- 
creasing passage number. providing the G418 selection 
was muintuincd (datu not shown). 
Western blotting of cell homogcntitc from this line, 
using on anti UGT antibody. showed high lcvcls of LL 
major immunorcactivc protein, 55.5 kDa, CO bc prcssnt 
(Fig. I). Some smaller molecular weight proteins wcrc 
also immune-detected which arc presumably dcgrada- 
tion products of the major protein. Thccxprcsscd biliru- 
bin UGT protein exhibited a similur molcculnr weight 
to the expressed phenol UGTs. HP1 was 55 kDu and 
HP4 was 56 kDa (Fig, I). 
3.3, LIGT-HP3 ccrm~~ve~ rile ghrcitroniduriort f hitirubitr 
The ability of UGT HP3 to glucuronidtltc the cn- 
dogcnous substrate bilirubin was dctcrmincd by HPLC 
assuy of V79-HP3 cells. A typiml HPLC clution profile 
is shown in Fig. 2. The results sho\v that UGT-HP3 
artcllyscd the conjugation of glucuronic acid with biliru- 
biin at a rstc comparoblc to that observed with human 
liwcr microsonrcs (Table I). This high activity system 
avoids the potential problems nssociatcd with using cx- 
trcmcly low UDP-glucursnic ucid conccntrutions. large 
amounts of protein or cxccssivcly long incubation 
times, required by other expression systems [13]. No 
activity towards bilirubin was dctcctcd in transfcctcd 
V79 cells stably cxprcssing other UGT-HP proteins 
(Table I). 
In humans, approximately 80% of bilirubin conjuc 
gates cxcrctcd in bile arc diglucuronidcs and the rcmain- 
dcr being monoglucuronidcs [ 141 UGT-HP3 homogc- 
natcs clearly catalyscd the formation of both mono- tend 
diglucuronidcs in in vitro incubation mixtures. Previ- 
ously the question has arisen whcthcr tlzc forrntition of 
the two natural bilirubin monoglucuronidc isomers (C- 
8 und C-12) dcpcnds on discrctc enzyme forms. In this 
study WC uncquivoclrlly demonstrate that both lhcsc 
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Fig. I. tmmunobloi analysis of human liver microsemsr und V79 cells stably cxprcssing UGTs using an antWCiT antibody. LNKS I-3, human 
liver microromcr from three different individuals (20 fig); lunc4, human kidney mirrofomu (2Org); lane S. V79 cells expressing UGT HP4: Jrnr 
6. homogcnutc V79 cells cxprcrriq HP3: lanrr 7 und 1, V79 cells expressing HPI. Lanes *7,2O~g. lnnc 8,40 yg of cell homogcnrrtc protein wus 
loaded. Molcculur weight markers, from rhc urns gel used for the immunoblot, stained with Ponscau reel WC shown on the right. 
isomers arc formed by a single haman UGT, The pcr- 
ccntngc of bifirubin diglucuronidcs formed (535%) was 
grcatcr than formed by incubution with human liver 
microsomcs (36%) under cquivalcnt conditions. The 
proportion of diglucuronidcs formed during in vitro 
incubations with liver extracts is dcpcndcnt on the con- 
centration of substrates used in the assay [I 51. und this 
variation of product dcpcndcnt on substrate conwntm- 
tion was also dcmonstratcd using Y79-HP3 ccl1 homo- 
genates (data not shown). Incubation of whole cells in 
culture with bilirubin may produce the glucuronidc for- 
mation pattern observed in vivo. 
3.4, Activity of UGT-HP3 EOW&S .s~~~kic~ric s rlx~~res 
The activity of the UGT-HP3 protein towards a fur- 
ther three substrates was tcstcd by TLC assays. Other 
sell lines stably cxprcnsing two other UGT-HP proteins 
(M Pi and HP4) were also studied as comparative con- 
trols. The results are shown in Table I. UGT-HP3 
showed a small level of activity towards 1 -naphthol but 
this substrate was more specifically glucuronidatsd by 
UGT-HP1, 4-Methylumbcllifcronc was observed to bc 
rclutivcly non-specifically glucuronidatcd at a similar 
rate by all UGT isocnzymcs confuming the value of this 
compound for general dctcction of glucuronidation, but 
also that it is usclcss as a specific probe for an inrtividuai 
UGT isoform. The conjugation of 1-nuphthol and 4- 
mcthylumbcllifcronc by UGT-HP3 indicates that as 
well as forming cstcr glucuronidcs of bilirubin. this cn- 
zymc was also capilble of the conjugation of small phc- 
nob. Such a result indicates that saturation of this cn- 
Tublc I 
Substrate spcciticity of UCifw stably cxprcsrd in V79 cells 
Subrlratcr UGT nctivilics 
(nmoVminlmg prolcin) 
HP1 HP3 HP4 :LM 
_---_- _ 
Bilirubin n.d, OA n.d, 0.9 i 0.5 
Prapofol n.d. n.d. 0.9 I.8 f 1.1 
~~.Mcthylumbcllircrolrc 0.8 26 f 6.3 
I-Nsphthol ::1 0.3 A:1 5.7 2 3.2 
- 
Data reported for cell homoyci~uIcr xc the avcrirgc of three rpnralc 
prcptirations. HLM, data from six prcparationr of human liver micro- 
some and S.D. 
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-. _ . _ . _ , \ 
0 10 20 90 40 
7lme (mlnulrr) 
;‘ip, 2. HPLC tlution profile of bilirubin glucuronidcs formed by 
V79-HP3 cells zmd human liver microsomcs. b) V79.HP3 cells: (b) 
human liver mirrosomcs; (c) unwnrfcctcd V79 cells. The bilirubin 
diglucuronidcr clubxl bctwccn I2 and I4 min. The Ct. Cl2 bilirubin 
monoglucuronidcr clufcd bctwccn 20 und 35 min. Unconju@cd 
bilirubin cluicd nt 37-11 min. 
rymc by phenols (including plant ulkaloids and drugs) 
may lead to jaundice, 
Propofoi (en intravenous anacsthctic), which appears 
to be 8 specific substrate for HP4, was not glucu= 
ronidatcd by the HP3 encoded protein. 
4,. CONCLUDING REMARKS 
WC have established a tissue cuiturc system in which 
the human UGTprotcin HP3 is stably expressed at high 
Icvcls, which provides us with a very useful model sys- 
tem for the study of this important human enzyme. The 
tissue culture system allows us to cvaluatc the substatc 
specificity of this cnzymc and to asssss its potential role 
in glucuronidution of other chcmiculs, including drugs. 
drb;rlu~~l~~~nitrrrrs: We gmlcfully %knowlcdw rlw fuxmcial support 
of rhc Sconirh Home nnd He&h Rcwrtmcnr. Medical RcscaKh 
Council end the Wcllcomc Trust. TX. &IS rpon~rcd by the Roksr 
l3orch Foundulion. Stuttyurt. Gcrmwy, and S.S. ws rupponcd by 
Nntion;ll Univcnily of Maluysiu. 
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